Zucara Therapeutics' Convertible Note Round

Zucara Therapeutics raised a round of funding on February 08, 2018.

Zucara Therapeutics, a spin-off of The Centre for Drug Research and Development (CDRD) and MaRS Innovation (MI), is developing drug therapy to prevent hypoglycemia in people with diabetes. The company…

Articles about Zucara Therapeutics' Convertible Note Round: